News

Crohn's the third indication for Skyrizi after psoriasis and psoriatic arthritis ... The FDA is also reviewing a lower 180mg maintenance dose. Thomas Hudson, AbbVie's chief scientific officer ...
The IL-23 pathway is already targeted by various injectable antibody-based drugs, including AbbVie's own Skyrizi (risankizumab) – which is FDA-approved for plaque psoriasis, psoriatic arthritis ...
Novo Nordisk slashed its spending on TV ads for Wegovy by almost 24% between April and May, from $31.6 million to $24.1 ...
Bimekizumab use for 4 years among patients with plaque psoriasis is associated with sustained efficacy outcomes and no new safety signals.
May 27, 2025 — Researchers have found that central body fat, especially around the abdomen, is more strongly linked to psoriasis risk than total body fat, particularly in women. This link ...
Additionally, some infections may exacerbate or trigger psoriasis, such as strep throat. Regardless of whether you are on a biologic or immunosuppressive medication for psoriasis, it’s essential ...
Stubborn, stubborn psoriasis. You retreat with the sun's rays, but barely. You force me to explain that you're not contagious, just ugly, and to stand around in long skirts feeling like a priggish ...